-DOCSTART- -X- O
ABSTRACT -X- _ O
: -X- _ O
Marine -X- _ B-Patient
sponges -X- _ I-Patient
and -X- _ I-Patient
their -X- _ I-Patient
associated -X- _ I-Patient
bacteria -X- _ I-Patient
have -X- _ O
been -X- _ O
proven -X- _ O
to -X- _ O
be -X- _ O
a -X- _ O
rich -X- _ O
source -X- _ O
of -X- _ O
novel -X- _ O
secondary -X- _ O
metabolites -X- _ O
with -X- _ O
therapeutic -X- _ O
usefulness -X- _ O
in -X- _ O
cancer -X- _ O
, -X- _ O
infection -X- _ O
, -X- _ O
and -X- _ O
autoimmunity. -X- _ O
In -X- _ O
this -X- _ O
study -X- _ O
, -X- _ O
79 -X- _ O
strains -X- _ O
belonging -X- _ O
to -X- _ O
20 -X- _ O
genera -X- _ O
of -X- _ O
the -X- _ O
order -X- _ O
Actinomycetales -X- _ O
and -X- _ O
seven -X- _ O
strains -X- _ O
belonging -X- _ O
to -X- _ O
two -X- _ O
genera -X- _ O
of -X- _ O
the -X- _ O
order -X- _ O
Sphingomonadales -X- _ O
were -X- _ O
cultivated -X- _ O
from -X- _ O
18 -X- _ O
different -X- _ O
Caribbean -X- _ O
sponges -X- _ O
and -X- _ O
identified -X- _ B-Outcome
by -X- _ I-Outcome
16S -X- _ I-Outcome
rRNA -X- _ I-Outcome
gene -X- _ I-Outcome
sequencing. -X- _ I-Outcome
Seven -X- _ I-Outcome
of -X- _ I-Outcome
these -X- _ I-Outcome
strains -X- _ I-Outcome
are -X- _ I-Outcome
likely -X- _ I-Outcome
to -X- _ I-Outcome
represent -X- _ I-Outcome
novel -X- _ I-Outcome
species. -X- _ I-Outcome
Crude -X- _ I-Outcome
extracts -X- _ I-Outcome
from -X- _ I-Outcome
selected -X- _ I-Outcome
strains -X- _ I-Outcome
were -X- _ I-Outcome
found -X- _ I-Outcome
to -X- _ I-Outcome
exhibit -X- _ I-Outcome
protease -X- _ I-Outcome
inhibition -X- _ I-Outcome
against -X- _ I-Outcome
cathepsins -X- _ I-Outcome
B -X- _ I-Outcome
and -X- _ I-Outcome
L -X- _ I-Outcome
, -X- _ I-Outcome
rhodesain -X- _ I-Outcome
, -X- _ I-Outcome
and -X- _ I-Outcome
falcipain-2 -X- _ I-Outcome
as -X- _ I-Outcome
well -X- _ I-Outcome
as -X- _ I-Outcome
immunomodulatory -X- _ I-Outcome
activities -X- _ I-Outcome
such -X- _ I-Outcome
as -X- _ I-Outcome
induction -X- _ I-Outcome
of -X- _ I-Outcome
cytokine -X- _ I-Outcome
release -X- _ I-Outcome
by -X- _ I-Outcome
human -X- _ I-Outcome
peripheral -X- _ I-Outcome
blood -X- _ I-Outcome
mononuclear -X- _ I-Outcome
cells. -X- _ I-Outcome
These -X- _ O
results -X- _ O
highlight -X- _ O
the -X- _ O
significance -X- _ O
of -X- _ O
marine -X- _ O
sponge-associated -X- _ O
bacteria -X- _ O
to -X- _ O
produce -X- _ O
bioactive -X- _ O
secondary -X- _ O
metabolites -X- _ O
with -X- _ O
therapeutic -X- _ O
potential -X- _ O
in -X- _ O
the -X- _ O
treatment -X- _ O
of -X- _ O
infectious -X- _ O
diseases -X- _ O
and -X- _ O
disorders -X- _ O
of -X- _ O
the -X- _ O
immune -X- _ O
system. -X- _ O
ELECTRONIC -X- _ O
SUPPLEMENTARY -X- _ O
MATERIAL -X- _ O
: -X- _ O
The -X- _ O
online -X- _ O
version -X- _ O
of -X- _ O
this -X- _ O
article -X- _ O
( -X- _ O
doi:10.1007 -X- _ O
/ -X- _ O
s10126-010-9349-0 -X- _ O
) -X- _ O
contains -X- _ O
supplementary -X- _ O
material -X- _ O
, -X- _ O
which -X- _ O
is -X- _ O
available -X- _ O
to -X- _ O
authorized -X- _ O
users -X- _ O
. -X- _ O

